Synthesis, crystal structure and DNA/protein binding of tetranuclear Cu(II) complexes with a double-open-cubane like core framework. by Paul,  Aparup et al.
Durham Research Online
Deposited in DRO:
20 August 2018
Version of attached ﬁle:
Accepted Version
Peer-review status of attached ﬁle:
Peer-reviewed
Citation for published item:
Paul, Aparup and Puschmann, Horst and Manna, Subal Chandra (2018) 'Synthesis, crystal structure and
DNA/protein binding of tetranuclear Cu(II) complexes with a double-open-cubane like core framework.',
Polyhedron., 155 . pp. 447-456.
Further information on publisher's website:
https://doi.org/10.1016/j.poly.2018.08.020
Publisher's copyright statement:
c© 2018 This manuscript version is made available under the CC-BY-NC-ND 4.0 license
http://creativecommons.org/licenses/by-nc-nd/4.0/
Additional information:
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for
personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in DRO
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full DRO policy for further details.
Durham University Library, Stockton Road, Durham DH1 3LY, United Kingdom
Tel : +44 (0)191 334 3042 | Fax : +44 (0)191 334 2971
http://dro.dur.ac.uk
Accepted Manuscript
Synthesis, crystal structure and DNA/protein binding of tetranuclear Cu(II)
complexes with a double-open-cubane like core framework
Aparup Paul, Horst Puschmann, Subal Chandra Manna
PII: S0277-5387(18)30485-6
DOI: https://doi.org/10.1016/j.poly.2018.08.020
Reference: POLY 13343
To appear in: Polyhedron
Received Date: 3 April 2018
Accepted Date: 2 August 2018
Please cite this article as: A. Paul, H. Puschmann, S. Chandra Manna, Synthesis, crystal structure and DNA/protein
binding of tetranuclear Cu(II) complexes with a double-open-cubane like core framework, Polyhedron (2018), doi:
https://doi.org/10.1016/j.poly.2018.08.020
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting proof before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  
Synthesis, crystal structure and DNA/protein binding of tetranuclear 
Cu(II) complexes with a double-open-cubane like core framework 
Aparup Paul,
a 
Horst Puschmann,
b
 and Subal Chandra Manna*
, a
 
a
Department of Chemistry and Chemical Technology, Vidyasagar University, Midnapore 
721102, West Bengal, India, E-mail: scmanna@mail.vidyasagar.ac.in, Fax: (91) (03222) 
275329. 
b
Department of Chemistry, University of Durham, South Road, Durham DH1 3LE, U.K. 
Abstract 
The copper(II) complexes [Cu4(L)2(HL)2(H2O)2]∙2(ClO4)∙2(H2O)∙DMF (1) and 
[Cu4(L)2(HL)2(H2O)2]∙(tp) (2) [H2L = 2-ethoxy-6-[(1-hydroxymethyl-propylimino)-methyl]-
phenol; tp = terephthalate] have been synthesized and characterized by single crystal X-ray 
diffraction and spectroscopic studies. The structural determination reveals that both the 
complexes are tetranuclear with a double-open-cubane like core framework. The 2D 
supramolecular structure of 1 and 3D supramolecular structure of 2 are formed through C-
H…π and hydrogen bonding interactions, respectively. At room temperature both the 
complexes exhibit fluorescence with quantum yields of 0.41 and 0.40. The interactions of the 
complexes with calf thymus DNA (CT-DNA) and serum albumins were investigated using 
electronic absorption and fluorescence spectroscopic techniques. The studies revels that the 
binding affinities of 1 and 2 with CT-DNA are of the order 8.86×10
5
 M
-1
 and 7.14×10
5
 M
-1
, 
respectively. Additionally, the interaction of the complexes with bovine serum albumin and 
human serum albumin were studied and the number of binding sites and binding constants 
were calculated using a double logarithm regression equation. The redox activities of the 
complexes were investigated in methanol solution by cyclic voltammetry. 
  
Keywords: Tetranuclear copper(II); Double-open-cubane; Crystal structure; CT-DNA 
binding; Serum albumin binding 
1. Introduction 
Transition metal clusters containing paramagnetic metal ions represent an important 
class of compounds for their potential application in the area of molecular magnetism [1] and 
their importance in the field of bioinorganic chemistry, as mimics for multi-metal active sites 
of metalloproteins [2]. Polynuclear copper complexes of various structures, e.g. dimeric [3a], 
square planar [3b], cyclic [3c], pin-wheel [3d], roof-shaped [3e] and cubane types [3f-3j], are 
reported in the literature due to their potential application in the area of magnetism [4], 
catalysis [5] and bioinorganic modelling [6]. Depending on the arrangement of the copper 
and oxygen atoms in the Cu4O4 unit various cubane geometries, such as regular cubane [7], 
single-open cubane [8], double open cubane [9] and face-sharing dicubane, have been 
reported [9b,10] in the literature. A literature survey reveals that many copper(II) based 
coordination compounds are used as metallo-pharmaceuticals [11] and these compounds play 
an important role in biology due to their antimicrobial [12], antifungal [13], antibacterial [14], 
antitumoral [15], antiviral [16], antipyretic [13a] and antidiabetic activities [17]. DNA is the 
primary intracellular target of antitumor drugs, since the interaction between small molecules 
with DNA can cause DNA damage and block DNA synthesis in cancer cells [18]. Therefore, 
under physiological conditions, metal complexes which are capable of binding and cleaving 
DNA are considered as potential candidates for use as therapeutic agents in medicinal 
applications [19]. On the other hand, studies of the binding of metal complexes with serum 
albumins is important to understand the potential of these compounds as drugs, as the nature 
and magnitude of the binding has a direct relation on drug delivery, drug absorption and the 
therapeutic efficiency [20]. Therefore, understanding and characterizing the interaction of 
drugs with DNA and serum albumin (HSA/BSA) are important for the development of new 
  
drugs. It is to note that the reported tetranuclear Cu(II)-cubane complexes mainly focused on 
the synthesis and magneto-structure correlation [4], whilst studies of the DNA/protein 
binding of tetranuclear Cu(II)-cubane complexes are rare in the literature [3g,3h]. 
As a part of our continuing work on Cu(II) complexes with Schiff base ligands, in the 
present contribution we have used a polydentate ligand (H2L), which functions as a chelating 
ligand with its versatile coordination modes (Scheme 1), and using H2L we synthesized two 
tetranuclear copper(II) complexes, [Cu4(L)2(HL)2(H2O)2]∙2(ClO4)∙2(H2O)∙DMF (1) and 
[Cu4(L)2(HL)2(H2O)2]∙(tp) (2) with a double open cubane structure. Interactions of the 
complexes with calf thymus DNA (CT-DNA) and serum albumins (BSA/HSA) have been 
studied with UV-vis and fluorescence spectroscopic techniques. 
 
2. Experimental 
2.1. Materials and physical measurements 
High purity 2-amino-1-butanol, 2-hydroxy-3-ethoxybenzaldehyde, calf thymus DNA, 
bovine serum albumin and human serum albumin were purchased from Aldrich Chemical Co. 
Inc. and used as received. All other chemicals used were analytical grade. Solvents used for 
the spectroscopic studies were purified and dried by standard procedures before use [21]. 
Elemental analyses (carbon, hydrogen and nitrogen) were performed using a Perkin-Elmer 
240C elemental analyzer. IR spectra were recorded as KBr pellets on a Bruker Vector 22FT 
IR spectrophotometer operating from 400 to 4000 cm
–1
. The NMR spectra of the ligand were 
recorded on A Bruker 400 MHz instrument. ESI-MS spectra of the compounds and HL in 
methanol were recorded on an Agilent Q-TOF 6500 mass spectrometer and the software used 
for mass analysis was Mass hunter. Electronic absorption spectra were obtained with a 
Shimadzu UV-1601 UV-vis spectrophotometer at room temperature. Quartz cuvettes with a 1 
  
cm path length and a 3 cm
3
 volume were used for all measurements. Emission spectra were 
recorded on a Hitachi F-7000 spectrofluorimeter. Room temperature (300 K) spectra were 
obtained in a methanolic solution using a quartz cell of 1 cm path length. The slit width was 5 
nm for both excitation and emission.  
The fluorescence quantum yield was determined using phenol as a reference and methanol 
medium for both the complexes and the reference. Emission spectra were recorded by 
exciting the complex and the reference phenol at the same wavelength, maintaining nearly 
equal absorbance (~ 0.1). The area of the emission spectrum was integrated using the 
software available in the instrument and the quantum yield was calculated [22] according to 
the following equation: 
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where Φs and Φr are the fluorescence quantum yield of the sample and reference, 
respectively. As and Ar are the respective optical densities at the wavelength of excitation, Is 
and Ir correspond to the areas under the fluorescence curve; and ηs and ηr are the refractive 
index values for the sample and reference, respectively. The fluorescence enhancement 
efficiency (%) was calculated by using the equation ]/)[( oo FFF  ·100and the corresponding 
quenching efficiency (%) by ]/)[( oo FFF  · 100 , where F0 and F are the maximum 
fluorescence intensities of the complex before exposure and in presence of the analyte, 
respectively. The Stern-Volmer equation F0/F = 1 + Ksv[complex]  (where F0 and F are the 
fluorescence intensities in the absence and presence of the complexes, Ksv is Stern-Volmer 
constant) was used to explain the fluorescence quenching phenomenon [22]. 
Electrochemical measurements performed under a dry argon atmosphere with a BAS Epsilon 
electrochemical system. A three-electrode assembly comprising a glassy carbon (for 
  
reduction) or Pt (for oxidation) working electrode, Pt auxiliary electrode and an aqueous 
Ag/AgCl reference electrode were used. Cyclic voltammetric (CV) measurements were 
carried out at 298 K using a methanolic solution of complexes (ca. 1 mM) and the 
concentration of the supporting electrolyte tetraethylammonium perchlorate (TEAM) was 
maintained at 0.1 M. The potentials reported were referenced against the Ag/AgCl electrode, 
which under the given experimental conditions gave a value of 0.36 V for the 
ferrocene/ferrocenium couple. 
 
2.2. X-ray crystallography 
Data collections for complexes 1 and 2 were carried out at 120 K on an Oxford 
Diffraction Gemini Ultra diffractometer. Cell refinement, indexing and scaling of the data 
sets were done with the CrysAlisPro package, Version 1.171.35.10 [23]. The structures were 
solved using the olex2.solve solution program [24] using the charge flipping algorithm and 
refined by the full matrix least-squares method based on F
2
 with all observed reflections [25]. 
All the calculations were performed using WinGX [26]. For 1, three of the four ligands 
exhibit some form of disorder in the side-chains. This disorder has been modelled in two sets 
(PART 1 and PART 2) with occupancies of 0.6 and 0.4. One of the perchlorates anions is 
also disordered in the same ratio. Standard methods to restrain distances and also some ADPs 
have been employed. These restraints are detailed in the embedded res file and also described 
explicitly in a textual way. The restraints did not affect the R factors in a negative way. 
Packing diagrams were obtained with the graphical program Diamond [27]. Crystal data and 
details of refinements are given in Table 1.  
 
 
  
2.3. Synthesis of the ligand and the complexes 
2.3.1. Synthesis of 2-ethoxy-6-[(1-hydroxymethyl-propylimino)-methyl]-phenol (H2L) 
A methanolic solution (50 ml) of a 1:1 mixture of 2-aminobutanol (1 mmol, 0.089 g) 
and 2-hydroxy-3-ethoxybenzaldehyde (1 mmol, 0.166 g) was refluxed for 3 h. The resulting 
yellow colored solution was cooled to room temperature and a solid yellow compound was 
obtained after evaporation of the solvent. Re-crystallization of the compound using methanol 
as the solvent resulted in yellow crystals. The crystalline solid was collected by filtration and 
dried in air to afford H2L. Yield: 0.197 g (83%). Anal. calc. for C13H19NO3 (237.29): C, 
65.80; H, 8.07; N, 5.90. Found: C, 65.82; H, 8.11; N, 5.22 (%).
1
H NMR (400 MHz, CDCl3, 
δ ppm): 0.796-0.877 (6H, m), 1.414-1.432 (2H, m), 2.586 (1H, s), 3.147-3.190 (1H, m), 
3.559-3.683 (2H, m), 4.013-4.048 (2H, m), 4.863 (1H, s), 6.671-6.850 (1H, d; 2H, m), 8.271 
(1H, s). 
13
C NMR (CDCl3, 100 MHz, δ ppm): 153.71 (Ar-C-OH), 165.37 (-CH=N-), 147.96 
(C-OEt), 123.08, 118.08, 117.40, 115.29 (Ar-C), 72.14 (-CH2-OH), 66.28 (=N-CH-), 64.34 
(-O-CH2), 24.98 (-CH2-), 14.83 (-CH3 of -OEt), 10.35 (-CH3). 
 
Scheme 1 The structure of H2L, and its coordination modes in complexes  1 and 2. 
2.3.2. Synthesis of the complexes 
Caution! Perchlorate salts of metals with organic ligands are potentially explosive. Only a 
small amount of the material should be prepared, and it should be handled with care. 
  
The complexes have been synthesized by adopting the procedures given in Scheme 2. 
 
Scheme 2 Synthesis of 1 and 2. 
 
2.3.2.1. [Cu4(L)2(HL)2(H2O)2]∙2(ClO4)∙2(H2O)∙DMF (1) 
A methanolic solution (15 ml) of a 1:1 mixture of triethylamine (1 mmol, 0.101 g) 
and H2L (1 mmol, 0.237 g) was added dropwise to a methanolic-DMF solution (10 ml) of 
copper perchlorate hexahydrate (1 mmol, 0.370 g) under stirring conditions. The deep green 
reaction mixture was stirred for an additional 2 hours and filtered. The filtrate was kept in an 
open atmosphere for slow evaporation and green single crystals suitable for X-ray diffraction 
quality were obtained after a few days. Yield: 81%. Anal. calc. for C55H85Cu4N5O25Cl2 
(1541.33): C,42.86; H, 5.56; N, 4.54. Found: C, 42.84; H, 5.38; N, 4.53 (%). IR (cm
-1
): 3430 
(vs), 2984 (vw), 1642 (vs), 1550 (vs), 1466 (s), 1413 (vs), 1373 (w), 1244 (vw), 1300 (s), 
1078 (s), 882 (vw), 632(vw).  
 
2.3.2.2.[Cu4(L)2(HL)2(H2O)2]∙(tp) (2) 
A methanolic solution (15 ml) of a 1:1 mixture of triethylamine (1 mmol, 0.101 g) 
and H2L (1 mmol, 0.237 g) was added dropwise to a methanolic solution (10 ml) of copper 
perchlorate hexahydrate (1 mmol, 0.370 g) under stirring conditions. To the resulting green 
solution an aqueous solution of sodium terephthalate (1 mmol, 0.21g) was added after 2 
hours and stirred for  an additional 1 hour, then filtered. The filtrate was kept in air for slow 
evaporation at room temperature and green single crystals suitable for X-ray diffraction were 
  
obtained after a few days. Yield: 76%. Anal. calc. for C60H78Cu4N4O18 (1397.46): C, 51.57; 
H, 5.63; N, 4.01. Found: C, 51.82; H, 5.34; N, 4.07 (%). IR (cm
-1
): 3435 (vs), 2984 (vw), 
1644 (vs), 1551 (vs), 1466 (s), 1414 (vs), 1373 (s), 1300 (s), 1244 (vw), 1079 (s), 882 (vw), 
664 (vw). 
 
2.4. Albumin binding studies 
Stock solutions of human serum albumin (HSA) and bovine serum albumin (BSA) were 
prepared in HEPES buffer (pH 7.2). Stock solutions of the complexes were prepared by 
dissolving the complexes in water. The absorption titration experiments were carried out by 
keeping the concentration of SA constant (4.75 × 10
-5
 M for BSA; 3.16 × 10
-5 
M for HSA), 
while varying the concentrations of the Cu(II) complexes (0 to 11.2 µM). The interactions of 
the compounds with the serum albumins were studied by recording the tryptophan 
fluorescence of HSA / BSA. To the solutions of serum albumin, the Cu(II) complexes were 
added at room temperature, and the quenching of emission intensities at 340 nm (λex, 280 nm) 
for BSA and 330 (λex, 280 nm) for HSA were recorded after the gradual addition of (20µL, 
0.3475mmol) an aqueous solution of the complexes. The Stern-Volmer constant (Ksv) and 
quenching rate constant (kq) were calculated using the Stern-Volmer equation and the relation 
Ksv = kqτ0, where τ0 is the fluorescence lifetime [28] of the tryptophan residue of serum 
albumin (~ 5 × 10
-9
 s). The binding constant (Kbin) and the number of binding sites (n) were 
calculated using the following Scatchard equation [29], where [complex] is the total 
concentration of the added complex. 
log[(Fo–F)/F] = log Kbin + n log[complex] 
 
2.5. DNA binding studies 
  
2.5.1. Electronic absorption spectral study 
The binding of the complexes with CT-DNA were studied by UV-vis spectroscopy to 
determine possible DNA-binding modes and binding constants. The UV spectra of the 
complexes were recorded with a fixed concentration of the complexes (5 µM) in water and 
varying the concentration of CT-DNA (0-15.48 µM) at room temperature in HEPES buffer 
(pH = 7.2). Intrinsic binding constants (Kib) of the complexes with CT-DNA were determined 
using the equation [30] 
     
       
 
     
       
  
 
          
 
where [DNA] is the concentration of CT-DNA,    is the extinction coefficient value of the 
complex at a given CT-DNA concentration,    and    are the extinction coefficients of the 
complex only and when fully bound to CT-DNA, respectively. A plot of [DNA]/(     ) vs 
[DNA] gives a straight line with 
 
        
 and  
 
           
 as the slope and intercept, 
respectively. From the ratio of the slope to the intercept, the values of Kib were calculated. 
2.5.2. Competitive binding fluorescence measurement 
Ethidium bromide competitive studies of each compound were carried out, using 
fluorescence spectroscopy to examine whether the tested compounds 1 and 2 can displace EB 
from the CT-DNA bound EB system. Aqueous solution of EB bounded CT-DNA (8 µM) 
solution prepared in HEPES buffer (pH 7.2). In the presence of DNA, ethidium bromide (EB) 
exhibits fluorescence (λem = 602 nm, λex = 500 nm) enhancement due to its intercalative 
binding to DNA. Competitive binding of the copper compounds with CT-DNA results in 
fluorescence quenching due to displacement of EB from CT-DNA. The DNA-intercalating 
effect of 1 and 2 were studied by gradual addition of the complexes (20 µL, 0.3475 mmol) to 
  
the EB-DNA complex. The fluorescence intensities of EB bounded CT-DNA were recorded 
with increasing concentrations of the Cu(II) complexes.   
 
3. Results and discussion   
3.1. Synthetic aspect 
The multisite coordinating ligand H2L was prepared by a one pot synthesis employing 
the condensation of 2-amino-1-butanol and 2-hydroxy-3-ethoxybenzaldehyde in methanol 
under refluxing conditions, and characterized by 
1
H and 
13
C NMR spectra (Figs. 1S and 2S). 
Using H2L, complexes 1 and 2 were synthesized at room temperature. 
 
3.2. Crystal structures of [Cu4(L)2(HL)2(H2O)2]∙2(ClO4)∙2(H2O)∙DMF (1) and 
[Cu4(L)2(HL)2(H2O)2]∙(tp) (2) 
The molecular structures of 1 and 2 are shown in Figs. 1 and 2. Selected bond lengths 
and angles are listed in Table 2. Both complexes crystallize in the triclinic system with the P-
1 space group. The core structures of both complexes are the same and the only difference is 
the presence of different lattice molecules (two perchlorate ions and one DMF molecule in 1, 
compared to one terephthalate ion in 2). Both the complexes possess a double open cubane 
core structure. The tetranuclear cubane core consist of four copper(II) centers, two 
bideprotonated Schiff base ligands [L
2-
] and two monodeprotonated Schiff base ligands [HL
-
]. Each HL
-
 ligand chelates two copper atoms via the μ2-η
1
:η1:η1:η2-O,O,N,O coordination 
mode, while the L
2-
 ligand chelates the other two copper centers along with connecting to the 
previous moieties with a μ3-alkoxido group, resulting in the μ3-η
1:η1:η3-O,N,O coordination 
mode, while the ethoxy oxygen atoms remain uncoordinated. Fig. 3 and Fig. 3S show a 
0simplified representation of the coordination environment around the four copper centers of 
  
1 and 2, respectively. For both the complexes, two copper ions are present in a distorted 
square pyramidal [Cu(1A) and Cu(3A) for 1; Cu(3) and Cu(4) for 2] geometry, whereas the 
other two metal centers are present in a distorted octahedral geometry [Cu(0A) and Cu(2A) 
for 1; Cu(1) and Cu(2) for 2]. The trigonality parameters [31] for five coordinated copper 
centers are calculated as (α-β)/60, where α and β are the two largest coordination bond 
angles. Hence a regular TBP structure with D3h symmetry has τ5 = 1 and for a regular C4v SP 
geometry τ5 = 0. The calculated τ5 values were 0.252 (Cu(1A)), 0.06 (Cu(3A)) for 1, and 
0.156 (Cu(3)), 0.026 (Cu(4)) for 2. This result indicates that the copper centers possess 
distorted square pyramidal geometries. The basal planes of the square pyramid for both the 
complexes are formed by the imine nitrogen, phenoxide oxygen and alcoholic oxygen atoms 
of the monodeprotonated HL
-
 ligand and the μ3-alkoxido oxygen atom of the L
2-
 ligand. The 
coordinated water molecule occupies the apical position of the square pyramid. The basal 
coordination bond lengths of the square pyramid are between 1.913(19) and 2.017(5) Å for 1 
and 1.906(13) and 2.018(8) Å for 2. The apical bond lengths are somewhat more distant, 
being at 2.327(5) Å for Cu(1A) and 2.372(6) Å for Cu(3A), respectively in 1, whereas they 
are 2.263(7) Å for Cu(3) and 2.271(7) Å for Cu(4) in 2 (Table 2). The coordination 
environment of other two metal centers [Cu(0A), Cu(2A) for 1 and Cu(1), Cu(2) for 2] 
remain distorted octahedral. The basal planes of the octahedron are formed by the imine 
nitrogen, phenoxido and alkoxido oxygen atoms from one L
2–
 ligand and the μ2-phenoxido 
oxygen atoms of the HL
-
 ligand, and the axial positions are the occupied by ethoxy oxygen 
atom of the same HL
-
 ligand and the alkoxido oxygen atom of another L
2–
 ligand. The 
equatorial bond distances are in the range 1.911(5)-2.016(4) Å for 1 and 1.902(7)-2.021(7) Å 
for 2, while relatively larger (due to Jahn-Teller distortion) the axial bond lengths vary from 
2.429(5) to 2.582(4) Å for 1 and 2.449(7) to 2.563(8) Å for 2. The long Cu(1A)-O(7) (3.039 
Å) and Cu(3A)-O(1AA) (2.991 Å) distances in 1 and Cu(3)-O(10) (3.003 Å) and Cu(4)-O(2) 
  
(2.959 Å) for 2 are responsible for the formation of the double open cubane core structure. 
The copper atoms are located at the vertices of a distorted tetrahedron with edge dimension 
ranges of 3.199(12)-3.888(12) Å for 1 and 3.147(23) -3.891(20) Å for 2 (Figs. 4S and 5S).  
Based on the Cu…Cu distances within Cu4O4 cubane cores, Alvarez et al. classify 
[32] copper cubanes into three types: (i) (2+4), where the Cu…Cu distances are two short and 
four long; (ii) (4+2), where the Cu…Cu distances are two long and four short; and (iii) (6+0), 
where the six Cu…Cu distances of the Cu4O4 cubane core are similar [32c]. However in 
complex 1, the Cu…Cu distances are 3.199(12), 3.250(10), 3.207(12), 3.406(12), 3.434(9) 
and 3.888(12) Å, and in 2, the Cu…Cu distances are 3.147(23), 3.193(20), 3.891(20), 
3.346(15), 3.351(17) and 3.309(18) Å. The Cu…Cu distances in 1 and 2 indicate that the 
Cu4O4 cubane cores of these complexes do not belong to any of the above categories as 
proposed by Alvarez et al.  
The lattice terephthalate ions in complex 2 form 1D supramolecular chains through four 
different types hydrogen bonding interactions, [O(3)-H(3)...O(17) = 1.73, O(5)-H(5B)...O(16) 
= 1.98, O(12)-H(12)...O(15) = 1.84 and O(13)-H(13A)...O(14) = 1.78 Å], with the cubane 
units (Fig. 4). 
 
3.3. Electronic absorption and fluorescence spectra of the complexes 
The electronic absorption spectra of the complexes show (Fig. 9S) significant 
transitions at 231 nm  (ε ~ 8.82 × 104 litre mole-1 cm-1 for 1 and 6.14 × 104 litre mole-1 cm-1 
for 2), 276 nm (ε ~ 4.62 × 104 litre mole-1 cm-1 for 1 and 2.94 × 104 litre mole-1 cm-1 for 2) 
and 370 nm (ε ~ 1.3 × 104 litre mole-1 cm-1 for 1 and 8.0 × 103 litre mole-1 cm-1 for 2). The 
results of the study on the luminescence properties are summarized in Table 3. Both the 
complexes exhibit red shifted emissions. On excitation at 370 nm, complex 1 exhibits a sharp 
emission band at 430 nm and two weak shoulders at 458 and 572 nm, whereas for complex 2 
  
upon excitation at 370 nm it exhibits a sharp emission band at 453 nm and a weak shoulder at 
564 nm.  The positions of the emission bands remain unchanged when λex is varied between 
(λex- 10) and (λex+ 10) nm (Fig. 10S). The calculated values of the fluorescence quantum 
yields (Фs) are 0.41 and 0.40 for 1 and 2, respectively. 
  
3.4. ESI mass spectroscopy 
The ESI mass spectra of the complexes were recorded using their methanolic solutions, 
which were prepared 24 h before the mass spectral study. ESI-mass spectra (Figs. 14S, 15S) 
of the complexes show peaks at m/z = 1231.98 and 1231.31 for complexes 1 and 2, 
respectively. The mass spectral peaks correspond to the cationic unit [Cu4(L)4(H2O)2]˙
+
 (calc. 
m/z = 1231.33 for both 1 and 2). This result indicates that tetranuclear copper clusters are 
stable in methanolic solution for 24 h. 
 
3.5.Protein binding studies 
A study of the interaction of the complexes with serum albumins has been performed 
using Uv-vis absorption and fluorescence spectroscopic techniques. 
3.5.1. Absorption spectral studies  
The changes in the electronic absorption spectra of BSA (3 ml, 0.475 µM aqueous 
solution) and HSA (3 ml, 0.316 µM aqueous solution) after the gradual addition (20 µL, 
0.3475 mmol) of the complex solutions (at pH 7.2 using HEPPES buffer) at a temperature of 
300 K are shown in Figs. 11S and 12S. The absorption intensities for both BSA and HSA 
were enhanced with a little blue shift (2 nm for 1; 3 nm for 2). The shift of the electronic 
spectral band revealed the existence of a static interaction between the SAs and the 
  
complexes [33]. The apparent association constants (Ka) were calculated from the 
1/[complex] vs 1/(Aabs-A0) plot (Fig. 5) using the following equation: 
 
         
 
 
       
   
 
                  
 
The values of the apparent association constant (Ka) are depicted in Table 4. The order of the 
association constant values are comparable to those reported for copper(II)-Schiff base 
complexes [34]. 
3.5.2. Fluorescence spectroscopic studies 
The changes in the emission spectra of the serum albumins upon addition of 
increasing concentrations (0-11.2 µM) of complexes are shown in Fig. 6. The fluorescence 
intensity of BSA at ~340 nm was quenched with a small blue shift (52.80%, 4 nm for 1; 
46.81%, 3 nm for 2). The 330 nm emission band of HSA was also quenched with a blue shift 
(45.47%, 4 nm for 1; 36.90%, 4 nm for 2). The blue shift primarily arises due to the presence 
of the active site of the protein in a hydrophobic environment [35]. From this observation it is 
clear that some interaction is taking place between the complexes and SAs. From the Stern-
Volmer equation [22] a linear relationship was obtained for the titration of the serum 
albumins using the complexes as a quencher (inset of Fig. 6). The calculated values of the 
Stern-Volmer quenching constant (KSV) and the quenching rate constant (Kq) (Table 4) for 
BSA binding are KSV = 9.51 (±0.09) × 10
4 
M
-1
, Kq = 1.90 (±0.09) × 10
13
 M
-1
S
-1 
for 1 and KSV 
= 7.99 (±0.01) × 10
4 
M
-1
, Kq = 1.59 (±0.01) × 10
13 
M
-1
S
-1
 for 2. For HSA binding the values 
are KSV = 7.45 (±0.07) × 10
4 
M
-1
, Kq = 1.49 (±0.07) × 10
13 
M
-1
S
-1 
for 1 and KSV = 5.12 (±0.06) 
× 10
4 
M
-1
, Kq = 1.02 (±0.06) × 10
13 
M
-1
S
-1 
for 2. The magnitudes of the KSV values indicate 
that both the complexes have a good fluorescence quenching ability. 
The UV-vis absorption spectra of the SAs show a noticeable change in the presence of the 
complexes. This indicates the presence of a static interaction between the SAs and complexes 
  
1 and 2. To have a deep insight into the quenching sequence, the equilibrium binding 
constant (Kbin) and number of binding sites (n) were also evaluated from the plot of log [(Fo− 
F)/F] versus log [complex] (Fig. 7) using the Scatchard equation [29]. The binding constants 
(Kbin) and the number of binding sites per albumin (n) for the complexes are given in Table 4. 
The calculated value of n is around 1 for all the complexes, indicating the existence of just a 
single binding site in the SAs for the complexes. 
3.6. Interaction with Calf-Thymus DNA 
Metal complexes bind to double-stranded DNA via covalent or non-covalent 
interactions. Non-covalent interactions with DNA involve three binding modes: intercalative 
binding, groove binding and electrostatic interactions [36]. Here the interactions of the 
complexes with CT-DNA were studied with UV-vis absorption and ethidium bromide (EB) 
displacement studies. 
3.6.1. UV-vis absorption spectral studies 
The absorption spectra of the complexes in the absence and presence of CT-DNA are 
shown in Fig. 8.  Addition of increasing amounts (0-15.48 µM) of CT-DNA results in an 
increase in the absorption intensity of the complexes and in a significant shift in the band 
position. For 1, the absorption bands at 231, 276 and 370 nm showed hyperchromism with 4 
nm red, 8 nm blue and 5 nm red shifts, respectively. For 2, the bands at 231, 276 and 370 nm 
showed hyperchromism with 6 nm red, 13 nm blue and 4 nm red shifts, respectively. From 
the plots of [DNA] / (εa-εf) versus [DNA] (inset of Fig. 8), linear relationships were obtained, 
and the intrinsic binding constants (Kib) were calculated from the ratio of the slope and the 
intercept. The calculated values of Kib are 1.25 (±0.22) × 10
4
 and 8.77 (±0.10) × 10
3
 M
-1
 
(Table 5) for 1 and 2 respectively. These results indicate that both the new copper complexes 
bind to the CT-DNA helix. 
  
3.6.2. Competitive binding between ethidium bromide and the complexes 
Absorption titration studies indicated that 1 and 2 effectively bind with CT-DNA. The 
nature of the binding between the complexes and CT-DNA was also studied adopting 
ethidium bromide (EB) displacement experiments. EB is a planar cationic dye and it is one of 
the most sensitive fluorescence probes which can bind to DNA through intercalation [37]. 
The changes of the emission spectra of EB bonded CT-DNA with increasing concentrations 
of the complexes are shown in Fig. 9. Due to the displacement of EB from the CT-DNA 
sequence by the complexes, the fluorescence intensity decreases as the number of binding 
sites on the DNA available for EB are also reduced. It is of note that 1 and 2 do not show any 
significant fluorescence when excited at 500 nm in the presence of CT-DNA. Furthermore 
the addition of the complexes to a solution containing only EB do not show any quenching of 
the free EB fluorescence.  
On gradual addition of the complexes (20µL, 0.3475 µM) to an EB bonded CT-DNA 
solution, the quenching of the emission of EB bounded CT-DNA was observed. The 602 nm 
emission band exhibited hypochromism up to 63.13% (for 1) and 52.53% (for 2) of the initial 
fluorescence intensity. The observed decrease in fluorescence intensity is due to displacement 
of EB from CT-DNA binding sites by the complexes [38]. The Stern-Volmer plots (inset of 
Fig. 9) for these fluorescence titrations show straight lines (R = 0.9796, 0.9963). The Ksv 
values have been derived from the slope of F0/F vs [complex] plots, and the values are 1.483 
(±0.11) × 10
5
 (for 1) and 9.78 (±0.08) × 10
4 
M
-1
 (for 2). The apparent DNA binding constant 
(Kapp) values were calculated using the equation [33a] 
KEB[EB] = Kapp[complex] 
 where the complex concentration is the value at a 50% reduction in the fluorescence 
intensity of EB, KEB (1.0 × 10
7 
M
−1
) is the DNA binding constant of EB, [EB] is the 
  
concentration of EB (8 μM). The Kapp values were found to be 8.86 × 10
5
 and 7.14 × 10
5
 for 1 
and 2, respectively and these results are given in Table 5. From these observed data, it is seen 
that both the complexes have comparable binding affinities. A comparison (Table 6) of the 
kinetic parameters of the CT-DNA interaction of the present compounds with reported 
tetranuclear cubane core (Cu4O4) complexes, [Cu4(L
1
)4] [3g] (H2L
1
; Schiff base of 1-amino-
2-propanol and salicylaldehyde) and {[Cu4(μ-L
2
)2(μ1,1,3,3-O2CH)](OH)·6H2O}[3h] (H3L
2
;1,3-
bis[3-aza-3-(1-methyl-3-oxobut-1-enyl)prop-3-en-1-yl]-2-(2-hydroxyphenyl)-1,3-
imidazolidine) show that 1 and 2 have comparable binding affinities with the reported 
compounds. 
 
3.7. Redox properties of the complexes  
The electrochemical behavior of the complexes was investigated in methanol solution by 
cyclic voltammetry in the potential range between 0.3 and 0.7 V. The voltammetric data are 
collected in Table 3 and the voltammograms are displayed in Fig. 10. The cyclic 
voltammograms show irreversible oxidation processes at 0.51 and 0.48 V for 1 and 2, 
respectively. 
 
4. Conclusion   
In summary, we have presented here the synthesis, crystal structure, DNA and protein 
binding studies of two 2-ethoxy-6-[(1-hydroxymethyl-propylimino)-methyl]-phenol (H2L) 
ligand based copper(II) complexes (1 and 2). The X-ray structural analysis shows that in both 
complexes the H2L ligand is present in its mono (HL
-
) and dianionic (L
2-
) forms with the μ2-
η1:η1:η1:η2-O,O,N,O and μ3-η
1:η1:η3-O,N,O coordination modes, respectively. Both the 
  
complexes possess a double open [Cu4O4] cubane core structure and the only difference is the 
presence of lattice solvents and anions. Supramolecular C-H…π interactions result in the 2D 
and 3D supramolecular architectures of 1 and 2, respectively. The CT-DNA and protein 
binding of the compounds were investigated using electronic absorption and emission 
spectroscopic techniques. The compounds bind effectively with CT-DNA in the order 10
4
 M
-
1
 through a non-intercalative interaction. A fluorescence spectroscopic study evidences that 
the interactions of 1 and 2 with serum albumins occur through a ground state association 
process.  
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Appendix A. Supplementary data  
CCDC 1544798 and 1544799 contain the supplementary crystallographic data for 1 and 2 
respectively. These data can be obtained free of charge via 
http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from the Cambridge Crystallographic 
Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-336-033; or e-mail: 
deposit@ccdc.cam.ac.uk. Tables for hydrogen interactions, C-H…π interactions; figures of 
NMR, FT-IR and electronic spectra and crystal structure data are provided as supporting 
information. 
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Table 1 Crystal data and structure refinement of complexes 1 and 2. 
Complex 1  2  
Empirical formula C55H85Cu4N5O25Cl2 C60H78Cu4N4O18 
Formula mass, g mol
–1
 1541.33 1397.46 
Crystal system Triclinic Triclinic 
Space group P-1           P-1          
a, Å 11.6628(6) 13.1269(12) 
b, Å 14.0257(7) 15.7400(15) 
c, Å 20.9237(6) 16.5893(11) 
α, deg 93.892(3) 93.042(7) 
β, deg 98.319(3) 104.161(7) 
γ, deg 107.142(4) 110.732(9) 
V, Å
3
 3214.0(3) 3071.2(5) 
Z 2 2 
D(calcd), g cm
–3
 1.577 1.509 
(Mo-K), mm–1 1.472 1.441 
F(000) 1582 1448 
Theta range, deg 1.9,  25.0 1.8,  25.0 
No. of collected data 47359 29770 
No. of unique data 11315 10798 
Rint 0.085 0.093 
Observed reflns [I> 2σ(I)] 8532 5375 
Goodness of fit (F
2
) 1.073 1.020 
Parameters refined 11315, 1041 10798,  783 
R1, wR2 (I >2σ(I)) [a] 0.0727, 0.1732 0.0918, 0.2707 
Residuals, e Å
–3
 -1.38, 1.53 -0.59, 0.88 
 
[a]
R1(Fo) = Fo–Fc / Fo, wR2(Fo2) = [w (Fo2 – Fc 2) 2/ w (Fo2) 2 ]½ 
 
 
  
Table 2 Coordination bond lengths (Å) and angles (º) for complexes 1 and 2. 
 
1 2 
Bond lengths 
Cu(0A)-O(2AA)        
 
1.912(5) 
 
Cu(1)-O(1)          
 
2.449(7) 
Cu(0A)-O(6)          2.433(4) Cu(1)-O(0AA)        1.953(7) 
Cu(0A)-O(7)          1.991(4) Cu(1)-O(6)          1.902(7) 
Cu(0A)-O(8)          1.963(5) Cu(1)-O(10)         2.005(8) 
Cu(0A)-O(9)          2.582(4) Cu(1)-O(11)         2.563(8) 
Cu(0A)-N(5)          1.940(5) Cu(1)-N(3)         1.943(12) 
Cu(1A)-O(1AA)        1.944(5) Cu(2)-O(1)          1.941(7) 
Cu(1A)-O(8)          1.918(4) Cu(2)-O(0AA)        2.500(8) 
Cu(1A)-O(0AA)        2.327(5) Cu(2)-O(2)          2.021(7) 
Cu(1A)-O(7AA)        2.017(5) Cu(2)-O(4)          2.528(8) 
Cu(1A)-N(4)         1.913(19) Cu(2)-O(8)          1.912(7) 
Cu(2A)-O(1AA)        2.016(4) Cu(2)-N(4)          1.940(9) 
Cu(2A)-O(5AA)        1.911(5) Cu(3)-O(0AA)        1.919(7) 
Cu(2A)-O(4AA)        2.429(5) Cu(3)-O(2)          1.979(7) 
Cu(2A)-O(8)          2.520(4) Cu(3)-O(3)          2.018(8) 
Cu(2A)-O(9)          1.955(5) Cu(3)-O(5)          2.263(7) 
Cu(2A)-N(6)          1.940(5) Cu(3)-N(1)         1.934(10) 
Cu(3A)-O(4)          2.372(6) Cu(4)-O(1)          1.921(7) 
Cu(3A)-O(7)          1.942(5) Cu(4)-O(10)         1.962(8) 
Cu(3A)-O(9)          1.917(4) Cu(4)-O(12)        1.973(10) 
Cu(3A)-O(11)         2.009(6) Cu(4)-O(13)         2.271(7) 
Cu(3A)-N(2)         1.983(18) Cu(4)-N(5)         1.906(13) 
Bond angles   
Cu(0A)-O(7)-Cu(3A) 109.3(2) Cu(1)-O(1)-Cu(2)   97.1(3) 
Cu(0A)-O(8)-Cu(2A)       92.06(18) Cu(1)-O(1)-Cu(4)          91.3(2) 
Cu(1A)-O(8)-Cu(2A)       91.21(16) Cu(2)-O(1)-Cu(4)         120.1(3) 
Cu(0A)-O(8)-Cu(1A)        124.5(2) Cu(1)-O(0AA)-Cu(2)   95.2(3) 
Cu(2A)-O(9)-Cu(3A)        123.2(2) Cu(1)-O(0AA)-Cu(3)         119.9(4) 
Cu(0A)-O(9)-Cu(2A)       90.41(18) Cu(2)-O(0AA)-Cu(3)          91.6(3) 
Cu(0A)-O(9)-Cu(3A)       89.66(16) Cu(2)-O(2)-Cu(3)         106.0(4) 
 
 
 
 
 
 
 
 
 
  
Table 3 Electronic absorption and emission spectra of 1 and 2. 
 UV-vis
a λmax; 
bε 
(M
-1
cm
-1
) 
Emission 
(nm) 
Δνc, 
(nm) 
Фs 
d
EOx (V),  
e
iac (µA)  
f
FT-IR, 
g
(cm
-1
) 
1 231 (8.82×10
4
), 
276 (4.62×10
4
), 
370    (1.3×10
4
) 
430 60 0.41 0.514,  
-7.109 
3430(br) [ν(O-H)], 2984 
[ν(C-H)], 1642(vs) [ν(H-O-
H)bending], 1550 [ν(C=N)] 
 
2 231 (6.14×10
4
), 
276 (2.94×10
4
), 
370    (8.0×10
3
) 
453 83 0.40 0.485, 
-2.334 
 
3435(br) [ν(O-H)], 2984 
[ν(C-H)], 1644 [νas(OCO)], 
1551 [ν(C=N)], 1414 
[νs(OCO)] 
Bold number indicates the excitation wavelength. [a] Wavelength in nanometers, [b] Molar 
extinction coefficient in M
-1 
cm
-1
 in methanol solvent. [c] Stoke shift, [d] Methanol solution 
(supporting electrolyte NEt4ClO4, working electrode glassy carbon, reference electrode 
Ag/AgCl, scan rate 100 mV/s), [e] Anodic current, [f] in KBr pellet, [g] wavenumber in cm
-1
. 
 
 
Table 4 Quenching constant (Kq), binding constant (Kbin), number of binding sites (n) and the 
values of the apparent association constant (Ka) for the interactions of complexes 1 and 2 
with BSA/HSA. 
 Complex Ksv (M
-1
) Kq (M
-1
S
-1
) Kbin (M
-1
) n Ka (M
-1
) 
BSA 1 9.51(±0.09)×10
4
 1.90(±0.09)×10
13
 8.51(±0.01)×10
4
 0.79 9.50(±0.07)×10
2
 
2 7.99(±0.01)×10
4
 1.59(±0.01)×10
13
 7.58(±0.02)×10
4
 0.73 6.63(±0.07)×10
2
 
HSA 1 7.45(±0.07)×10
4
 1.49(±0.07)×10
13
 7.17(±0.02)×10
4
 0.83 6.19(±0.09)×10
3
 
2 5.12(±0.06)×10
4
 1.02(±0.06)×10
13
 6.30(±0.03)×10
4
 0.76 3.47(±0.11)×10
3
 
 
 
Table 5 Electronic spectral parameters of complexes 1 and 2 bound to CT-DNA. 
 λmax (nm) change in emission Δε (%) Ksv(M
−1
) Kib(M
-1
) Kapp (M
−1
) 
1 602 hypochromism 63.13 1.483(±0.11)×10
5
 1.25(±0.22)×10
4
 8.86×10
5
 
2 602 hypochromism 59.09 9.78(±0.08)×10
4
 8.77(±0.10)×10
3
 7.14×10
5
 
 
Table 6 Kinetic parameters of the interaction of Cu(II) cubane compounds with CT-DNA. 
Compound Kib Ksv Ref. 
[Cu4(L)2(HL)2(H2O)2]∙2(ClO4)∙DMF (1) 1.25×10
4
 1.483×10
5
 This work 
[Cu4(L)2(HL)2(H2O)2]∙(tp) (2) 8.77×10
3
 9.78×10
4
 This work 
Cu4(L
1
)4 4.50×10
3
 - [3g] 
[Cu4(μ-L
2
)2(μ1,1,3,3-O2CH)](OH)·6H2O 3.37×10
4
 4.73×10
4
 [3h] 
[Cu4((HL
3
)2(H2L
3
)2(H2O)(C2H5OH)]·2(ClO4)·2(C2H5OH) 1.35×10
4
 1.69 [3i] 
[Cu4(H2L
4
)4·2H2O]·5H2O 1.48×10
4
 - [3j] 
[Cu4(H2L
4
)4·4H2O] 2.54×10
4
 - [3j] 
  
H2L
1
 = Schiff base of 1-amino-2-propanol and salicylaldehyde; H3L
2
 =1,3-bis [3-aza-3-(1- 
methyl-3-oxobut-1-enyl)prop-3-en-1-yl]-2-(2-hydroxyphenyl)-1,3-imidazolidine; H3L
3
 = 2-
ethyl-2-((2-hydroxy-3-methoxybenzylideneamino)propane-1,3-diol); H4L
4
 = 2-[(2-hydroxy-
3-methoxy-benzylidene)-amino]-2-hydroxymethyl-propane-1,3-diol. 
 
Captions of the Figures 
Fig.1. Molecular structure of 1 (lattice DMF, H2O molecules and hydrogen atoms are 
omitted). Only one out of the two orientations of the disordered perchlorate anion and one out 
of two disordered -CH2-CH3 side chains of the three Schiff base ligands are shown for clarity. 
Fig. 2. Molecular structure of 2.The hydrogen atoms are omitted for clarity. 
Fig. 3. Simplified representation of the tetranuclear copper(II) core in 1. 
Fig. 4. 1D supramolecular structure of 2 formed by hydrogen bonding interactions with the 
lattice terephthalate anion.  
Fig. 5. Plot of 1/[complex] vs 1/ (Aobs-A0) for the interactions of complexes 1 and 2 with 
serum albumins.  
Fig. 6. Fluorescence spectra of BSA (λex = 280 nm; λem = 340 nm) and HSA (λex = 280 nm; 
λem = 330 nm) in the presence of increasing amounts of complex 1 [(A) for BSA, (B) for 
HSA] and complex 2 [(C) for BSA, (D) for HSA]. Arrows show the emission intensity 
changes upon increasing the complex concentration. Inset: Stern-Volmer plot. 
Fig. 7. Scatchard plots for complexes 1 and 2 with BSA / HSA. (Here [complex] is the total 
concentration of the added complex). 
Fig. 8. Absorption spectra of complexes [(A) for 1 and (B) for 2] in the absence (black line) 
and in presence (other lines) of increasing amounts of CT-DNA, at room temperature. Inset: 
  
show the plots of [DNA]/(εa-εf) vs. [DNA]. The arrows show the absorbance change with 
increasing CT-DNA concentration. 
Fig. 9. Effect of addition of complexes 1 (A) and 2 (B) on the emission intensity of EB 
bonded CT-DNA. Inset: Stern-Volmer  plots of the fluorescence titrations. 
Fig. 10. Cyclic voltammograms of 1 (black) and 2 (red). 
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Tetranuclear Cu(II) complexes with double-open-cubane like core frameworks were 
synthesized and characterized by crystal structure analysis. Interactions of the complexes 
with serum albumins and CT-DNA were studied using electronic absorption and fluorescence 
spectroscopic techniques.  
 
 
